1-3 of 3
Mercedes Garayoa
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Novel Pan-PIM Kinase Inhibitor, PIM447, Displays Dual Antimyeloma and Bone-Protective Effects, and Potently Synergizes with Current Standards of Care

Teresa Paíno, Antonio Garcia-Gomez, Lorena González-Méndez, Laura San-Segundo, Susana Hernández-García, Ana-Alicia López-Iglesias, Esperanza M. Algarín, Montserrat Martín-Sánchez, David Corbacho, Carlos Ortiz-de-Solorzano, Luis A. Corchete, Norma C. Gutiérrez, María-Victoria Maetos, Mercedes Garayoa, Enrique M. Ocio
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (1): 225–238.
https://doi.org/10.1158/1078-0432.CCR-16-0230
Published: 02 January 2017
View article titled, The Novel Pan-PIM Kinase Inhibitor, PIM447, Displays Dual Antimyeloma and Bone-Protective Effects, and Potently Synergizes with Current Standards of Care
Open the PDF for The Novel Pan-PIM Kinase Inhibitor, PIM447, Displays Dual Antimyeloma and Bone-Protective Effects, and Potently Synergizes with Current Standards of Care in another window
Includes: Supplementary data
Journal Articles

Preclinical Activity of the Oral Proteasome Inhibitor MLN9708 in Myeloma Bone Disease

Antonio Garcia-Gomez, Dalia Quwaider, Miriam Canavese, Enrique M. Ocio, Ze Tian, Juan F. Blanco, Allison J. Berger, Carlos Ortiz-de-Solorzano, Teresa Hernández-Iglesias, Anton C.M. Martens, Richard W.J. Groen, Joaquín Mateo-Urdiales, Susana Fraile, Miguel Galarraga, Dharminder Chauhan, Jesús F. San Miguel, Noopur Raje, Mercedes Garayoa
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (6): 1542–1554.
https://doi.org/10.1158/1078-0432.CCR-13-1657
Published: 13 March 2014
View article titled, Preclinical Activity of the Oral Proteasome Inhibitor MLN9708 in Myeloma Bone Disease
Open the PDF for Preclinical Activity of the Oral Proteasome Inhibitor MLN9708 in Myeloma Bone Disease in another window
Journal Articles

Mitogen-Activated Protein Kinase Phosphatase-1 Is Overexpressed in Non-Small Cell Lung Cancer and Is an Independent Predictor of Outcome in Patients

Silvestre Vicent, Mercedes Garayoa, José M. López-Picazo, María D. Lozano, Gemma Toledo, Frederik B. J. M. Thunnissen, Ramón G. Manzano, Luis M. Montuenga
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (11): 3639–3649.
https://doi.org/10.1158/1078-0432.CCR-03-0771
Published: 01 June 2004
View article titled, Mitogen-Activated Protein Kinase Phosphatase-1 Is Overexpressed in Non-Small Cell Lung Cancer and Is an Independent Predictor of Outcome in Patients
Open the PDF for Mitogen-Activated Protein Kinase Phosphatase-1 Is Overexpressed in Non-Small Cell Lung Cancer and Is an Independent Predictor of Outcome in Patients in another window